我院近5年抗心绞痛药和血管扩张药使用分析

摘要

Objective To analyze the using situation and tendency of the drugs against angina pectoris as well as angiectasis ,and to provide references for the hospital drugs management .Methods We chose the anti-angina and vasodilating drugs using records from HIS database of network management system during 2012-2016 ,and calculated DDDs according to the WHO recommended daily dose ,contraindication and drug instruction .Results In the five years ,the anti-angina and vasodilating durgs application showed a trend of growing ;the injection was more than 70％ and was increasing ;meanwhile ,sustained release tablets and controlled release tablets was on the rise .The sales amount of Salvia Miltiorrhiza and Ligustrazine injection (5 mL) ranked in the first and the DDDs ranked in the No .3 .Conclusion It is reasonable for the use of anti-angina and vasodilating drugs in our hospital ,and it is helpful to increase rationality in clinical on the basis of correct understanding the application scope of drugs .%目的 分析我院近5年抗心绞痛药和血管扩张药的使用情况及用药趋势,为临床合理用药和医院药品规范管理提供参考依据.方法 选取2012～2016年该院网络管理系统H IS数据库中抗心绞痛药和血管扩张药使用记录,根据W H O推荐的日用剂量、用药禁忌和药品说明书确定各种药品的日限定剂量(DDD),计算用药频度(DDDs).结果 5年间该院抗心绞痛药和血管扩张药的使用总量呈增长趋势;注射剂占70％ 以上,且呈逐年上升趋势,缓、控释片剂的使用呈增长趋势.其中丹参川芎嗪注射液(5 mL)金额排序第1,DDDs排序第3.结论 抗心绞痛药和血管扩张药在该院的使用基本合理,熟知抗心绞痛和血管扩张药的应用范围,可提高临床合理用药率.